Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study. - Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Thalme, Anders; Girard, Pierre-Marie; Wong, Alexander; Porteiro, Norma; Swindells, Susan; Reynes, Jacques; Noe, Sebastian; Harrington, Conn; Español, Carlos Martín; et al. (Clinical Infectious Diseases, 2023)